Crizanlizumab for RVCL
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Retina | retinal vasculopathy
-
Age: Between 18 - 99 Years
-
Gender: Male or Female
Recruitment Status
Enrolling By InvitationIf you need assistance finding a non-cancer study or if you have any questions, please email psom-ocr@pobox.upenn.edu